CHRONOSCALE CORPORATION (CHRN)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
$20.26+0.90%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CHRN
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Execute and expand the AI infrastructure deployment in partnership with Microsoft, focusing on a 50-megawatt AI compute project in North America.
Newly stated in 2026-Q2. The company announced a strategic partnership with Microsoft for a planned 50 MW AI compute deployment integrating NVIDIA systems and advanced cooling. This is a new strategic growth initiative with no prior quarters for comparison, so delivery trajectory is not yet established.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated weak grew net income 53% of the time over the next year (vs 58% for the rest of the cohort, n=6963).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“ChronoScale Announces AI Infrastructure Partnership with Microsoft for 50 MW AI Compute Deployment in North America”
Complete the divestiture of Ekso Bionics subsidiary to concentrate operations solely on the cloud business segment.
Stated in 2 of last 2 quarters. Management committed to divesting Ekso Bionics to focus on cloud business, with expected completion in first half of 2026. Financials show ongoing operating losses and no revenue from Ekso, indicating partial progress but no clear financial impact yet; trajectory is mixed.
“Board committed to divest Ekso Bionics and focus solely on cloud business, expecting completion in first half of 2026.”
“Company is providing supplemental disclosure related to Cloud as of fiscal years ended May 31, 2025 and 2024.”
Focus on reducing operating losses and increasing gross profit margins to improve financial health.
Stated in 6 of last 6 quarters. Operating income worsened from -$2.2M in 2024-Q4 to -$5.6M in 2026-Q1, while gross profit declined from $2.7M to $1.1M over the same period. Despite management's focus on managing losses and improving gross profit, financials show a declining trajectory, indicating limited progress.
“Operating income was negative $5.6 million with gross profit of $1.1 million.”
“Gross profit was $1.7 million; operating income not disclosed.”
“Operating income negative $1.4 million with gross profit of $2.5 million.”
“Operating income negative $4.0 million with gross profit of $0.8 million.”
“Operating income negative $3.4 million with gross profit of $1.8 million.”
“Operating income negative $2.2 million with gross profit of $2.7 million.”
Secure capital through debt and equity to support operations and growth initiatives.
Newly stated in 2026-Q2. The company secured an unsecured line of credit up to $100 million with Applied Digital Corporation to support capital needs. This is a recent capital allocation action with no prior quarters for comparison, so delivery trajectory is not yet established.
“Entered into an unsecured Demand Grid Promissory Note with Applied Digital Corporation for up to $100 million line of credit.”
Over the trailing year it converted 0.56x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
31 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Industrials names rated volatile grew net income 58% of the time over the next year (vs 57% for the rest of the cohort, n=2592).
Not investment advice. As of 2026-09-04.